Could changes to ADHD meds be a game-changer or a risk?

Pharmac is now funding a new medicine and has removed renewal criteria for ADHD treatments.  Advocates are welcoming the move – saying it’s a game-changer that will save the health system tens of millions of dollars. But, there are warnings it could lead to over-diagnosing and over-prescribing. Today on The Front Page, co-founder of DivergenThinking and registered psychologist, Anton Ashcroft joins us to discuss. Follow The Front Page on iHeartRadio, Apple Podcasts, Spotify or wherever you get your podcasts. You can read more about this and other stories in the New Zealand Herald, online at nzherald.co.nz, or tune in to news bulletins across the NZME network. Host: Chelsea DanielsSound Engineer/Producer: Richard MartinProducer: Ethan SillsSee omnystudio.com/listener for privacy information.